Supplements · Sweeteners · Metabolic & Cardiometabolic
stevia improves glycemic control in diabetes
In plain terms: Does stevia help control blood sugar if you have diabetes?
Part of: • Stevia
Not in any lasting way that's been proven. There's a real short-term signal (one high-dose meal study blunted the glucose spike) and supportive animal data, but the longer human trials and a Cochrane review find no reliable improvement in HbA1c or fasting glucose. Stevia is fine as a sugar substitute, but it isn't a blood-sugar treatment.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
Beyond simply not raising blood sugar, the stronger claim that stevia actively improves diabetes control is not supported by durable human evidence.
The evidence (11)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Nichol AD et al. 2018 · Eur J Clin Nutr | meta-analysis | tested-null | moderate | Meta (NNS class incl. stevia): no significant glycemic impact in most comparisons; stevia underrepresented. |
| Kang Y et al. 2025 · Nutrients | animal | supports | low | Preclinical SR (40 animal + 5 cell studies): steviol glycosides improve glucose metabolism; authors state CLINICAL confirmation still needed. |
| Barriocanal LA et al. 2008 · Regul Toxicol Pharmacol | RCT | tested-null | moderate | 3-mo RCT (T2D, sweetener dose): NO significant change in fasting glucose or HbA1c vs baseline. |
| Bundgaard Anker CC et al. 2019 · Nutrients | meta-analysis | tested-null | moderate | SR/meta (T2D biomarkers): some acute postprandial signal but NO consistent effect on HbA1c or long-term fasting glucose. |
| Stamataki NS et al. 2020 · Nutrients | RCT | tested-null | low | 12-wk RCT (healthy adults): daily stevia did not significantly change glycemia. |
| Gregersen S et al. 2004 · Metabolism | RCT | supports | moderate | Acute RCT (12 T2D): 1 g stevioside cut postprandial glucose iAUC 18%, raised insulinogenic index ~40% - acute/postprandial only. |
| Chen J et al. 2006 · APMIS | in-vitro | supports | low | Isolated islets: stevioside enhanced glucose-stimulated insulin secretion without desensitizing beta-cells - mechanism only. |
| Concha Celume F et al 2026 · study_type: animal | animal | tested-null | low | Mice: parental stevia (0.1mg/mL, 16wk) vs water; F0 OGTT unchanged; F1 male Stevia mildly altered gene expr (Tlr4/Tnf up), normalized by F2; no direct glycemic-control benefit shown |
| Lohner S et al. 2020 · Cochrane Database Syst Rev | meta-analysis | contradicts | high | Cochrane review (NNS in diabetes): insufficient / low-certainty evidence that NNS incl. stevia improves glycemic outcomes. |
| Abudula R et al. 2004 · Metabolism | in-vitro | supports | low | Isolated islets: RebA dose-dependently stimulated insulin secretion (glucose/calcium-dependent) - mechanism only. |
| Jeppesen PB et al. 2003 · Metabolism | animal | supports | low | Diabetic rats: stevioside improved glucose tolerance and first-phase insulin - mechanism only. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.